[Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
CONCLUSION: Dermatologists must be able to recognise this rare entity of "pseudo-dermatomyositis" and then discontinue statin intake if present and carry out further investigations consisting of muscle biopsy and serological tests.
PMID: 30929872 [PubMed - as supplied by publisher]
Source: Annales de Dermatologie et de Cenereologie - Category: Dermatology Authors: Merlant M, Fite C, Kottler D, Maisonobe L, Dossier A, Deschamps L, Descamps V Tags: Ann Dermatol Venereol Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Cholesterol | Crestor | Dermatology | Dermatomyositis | Lupus | Rosuvastatin | Skin | Skin Biopsy | Statin Therapy | Study